View information for CIDP or Chronic ITP

Privigen Connect provides
patient support
all in one place

CSL Behring is committed to making sure you have the best experience possible with Privigen. That’s why CSL Behring offers services to help make Privigen therapy accessible and affordable.

Privigen Connect resource center provides services to help you start and continue Privigen therapy

Copay Icon

Copay Support Program

The Copay program helps eligible people* with commercial insurance by assisting with out-of-pocket expenses for Privigen

* Subject to terms and conditions of the copay assistance program. To read the full terms and conditions, visit https://www.cslbehring.com/patients/support-and-assistance/copay-terms-and-conditions. CSL Behring reserves the right to rescind, revoke, or amend the program at any time without notice.

Assurance Icon

Support If You Lose Your Insurance

CSL Behring is the only IVIg manufacturer to offer a loyalty program. This program allows eligible patients to continue receiving Privigen even if you have a lapse in your insurance coverage.

Enrollment required. Subject to terms and conditions. For the Assurance program, visit cslbehringassurance.com.

PAP Icon

Patient Assistance Program

Helps provide therapy to qualified people who are uninsured or underinsured.

Get the patient support you need with Privigen Connect

Privigen Connect logo

Call 1-877-355-4447
Monday–Friday
from 8 am to 8 pm Eastern Time.

Privigen patient education brochure

Get information to help you talk to your doctor about Privigen IVIg therapy for PI. Download your copy today:

PI Patient Brochure thumbnail

Make the most of Privigen therapy

Download the PI Brochure

Additional resources for you

If you are living with PI, you may want additional support and information. Check out the links below for general information.

National Organization for Rare Disorders (NORD)

NORD is a nonprofit patient advocacy organization that is committed to the identification, treatment, and cure of rare diseases and disorders. Along with more than 300 patient-organization members, NORD provides education programs, advocacy, research, and patient services.

National Family Caregivers Association

Also known as the Caregivers Action Network (CAN) is a national non-profit organization that provides education, peer support, and resources to family caregivers across the country free of charge.

National Institutes of Health

A part of the U.S. Department of Health and Human Services, NIH is the largest biomedical research agency in the world. NIH investigates the nature and behavior of living systems and applies the findings to enhance health, lengthen life, and reduce illness and disability.

National Library of Medicine (NLM)

The National Library of Medicine (NLM) is part of the National Institutes of Health, providing print and electronic information on a wide range of topics. The NLM is a reliable source of health information about diseases, conditions, and wellness issues, and servesas as a clearinghouse for clinical trials.

Resources for PI

Immune Deficiency Foundation (IDF)

Healthcare professionals, researchers, advocates, patients, and their families working together to improve the diagnosis, treatment, and quality of life of people affected by primary immunodeficiency.

International Patient Organization for Primary Immunodeficiencies (IPOPI)

International nonprofit advocate for primary immunodeficiency (PID) patients. Works with doctors, politicians, regulators, and the pharmaceutical industry to improve awareness, access to early diagnosis, and optimal treatments PID.

The Jeffrey Modell Foundation (JMF)

Global resource for up-to-date information and support related to primary immunodeficiency disorders. Devoted to early diagnosis and effective treatment of PID through research, education, advocacy, awareness, and screening.

American Autoimmune Related Diseases Association (AARDA)

Supports research and awareness of autoimmune diseases to advance diagnosis and effective treatment.

You are now leaving the current website.

Do you want to continue?